Scientists hunt blood for genetic keys to chemo success
NCT ID NCT00959556
Summary
This study aimed to find genetic markers in the blood that might predict how well breast cancer patients respond to chemotherapy. Researchers collected blood samples from patients who were receiving standard first-line chemotherapy drugs. The goal was to gather knowledge to help doctors personalize future treatment plans, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Oscar Lambret
Lille, 59020, France
Conditions
Explore the condition pages connected to this study.